Global /China /Healthcare /Drug Manufacturers - General /300233

Shandong Jincheng Pharmaceutical Group Co., Ltd.

300233

• SHE: 300233 • Delayed

15.52CNY -0.8%

2.28 USD

As of 27 June 2026, Shandong Jincheng Pharmaceutical Group Co., Ltd. has a market cap of $873.61M USD, ranking #11476 globally and #3344 in China. It ranks #1043 in the Healthcare sector, and #392 in the Drug Manufacturers - General industry.

Global Rank

11476

1d: -

1w: -

1m: -

Country Rank

3344

Sector Rank

1043

Industry Rank

392

Key Stats

Market Cap

$873.61MUSD

5.93B CNY

Enterprise Value

$790.17MUSD

5.37B CNY

Revenue (TTM)

$407.21MUSD

2.77B CNY

EBITDA (TTM)

$65.66MUSD

446.62M CNY

Net Income (TTM)

$9.85MUSD

66.93M CNY

EBITDA Margin

16%

Profit Margin

2.4%

PE Ratio

85.8

PS Ratio

2.1

PB Ratio

1.6

EV/EBITDA

12.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jiaquan Li open_in_new

Employees

3,515

Founded

2004

Website

jinchengpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	-2.6%	10%	-0.5%	-8.3%	12%	2.3%	-22%	-33%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300233 山东金城医药集团股份有限公司 Class A ISIN: CNE100001500 Shares Out.: Shares Outstanding: 379.332M¹ Shares Float: 296.858M² TV: TradingView: SZSE: 300233 SA: Stock Analysis: SHE: 300233 YF: Yahoo Finance: 300233.SZ GF: Google Finance: SHE: 300233 BA: Barron's: 300233 MS: Morningstar: XSHE: 300233	15.52 CNY	TV: TradingView: SZSE: 300233 SA: Stock Analysis: SHE: 300233 YF: Yahoo Finance: 300233.SZ GF: Google Finance: SHE: 300233 BA: Barron's: 300233 MS: Morningstar: XSHE: 300233

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shandong Jincheng Pharmaceutical Group Co., Ltd.

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin pharmaceutical intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. The company was founded in 2004 and is based in Zibo, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.73B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.53B 336.36B CNY 6K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.5B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.79B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.48B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 87K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 63K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 41K%	97.4	United States
Roche Holding AG SIX: RO	$316.45B 256.25B CHF 36K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.53B 215.59B GBP 32K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 31K%	15.1	United States

chevron_leftBack